Jeannette Potts - Net Worth and Insider Trading

Jeannette Potts Net Worth

The estimated net worth of Jeannette Potts is at least $1 Million dollars as of 2024-12-03. Jeannette Potts is the Chief Legal Officer of uniQure NV and owns about 91,819 shares of uniQure NV (QURE) stock worth over $654,669. Jeannette Potts is also the See Remarks of Forma Therapeutics Holdings Inc and owns about 22,358 shares of Forma Therapeutics Holdings Inc (FMTX) stock worth over $447,384. Details can be seen in Jeannette Potts's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jeannette Potts has not made any transactions after 2024-06-13 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Jeannette Potts

To

Jeannette Potts Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Jeannette Potts owns 2 companies in total, including Forma Therapeutics Holdings Inc (FMTX) , and uniQure NV (QURE) .

Click here to see the complete history of Jeannette Potts’s form 4 insider trades.

Insider Ownership Summary of Jeannette Potts

Ticker Comapny Transaction Date Type of Owner
FMTX Forma Therapeutics Holdings Inc 2022-02-23 See Remarks
QURE uniQure NV 2024-06-13 See Remarks

Jeannette Potts Latest Holdings Summary

Jeannette Potts currently owns a total of 2 stocks. Among these stocks, Jeannette Potts owns 91,819 shares of uniQure NV (QURE) as of June 13, 2024, with a value of $654,669 and a weighting of 59.4%. Jeannette Potts also owns 22,358 shares of Forma Therapeutics Holdings Inc (FMTX) as of February 23, 2022, with a value of $447,384 and a weighting of 40.6%.

Latest Holdings of Jeannette Potts

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
QURE uniQure NV 2024-06-13 91,819 7.13 654,669
FMTX Forma Therapeutics Holdings Inc 2022-02-23 22,358 20.01 447,384

Holding Weightings of Jeannette Potts


Jeannette Potts Form 4 Trading Tracker

According to the SEC Form 4 filings, Jeannette Potts has made a total of 1 transactions in uniQure NV (QURE) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in uniQure NV is the sale of 4,781 shares on June 13, 2024, which brought Jeannette Potts around $23,809.

According to the SEC Form 4 filings, Jeannette Potts has made a total of 1 transactions in Forma Therapeutics Holdings Inc (FMTX) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Forma Therapeutics Holdings Inc is the sale of 4,672 shares on February 23, 2022, which brought Jeannette Potts around $45,692.

Insider Trading History of Jeannette Potts

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Jeannette Potts Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Jeannette Potts Ownership Network

Ownership Network List of Jeannette Potts

No Data

Ownership Network Relation of Jeannette Potts

Insider Network Chart

Jeannette Potts Owned Company Details

What does Forma Therapeutics Holdings Inc do?

Who are the key executives at Forma Therapeutics Holdings Inc?

Jeannette Potts is the See Remarks of Forma Therapeutics Holdings Inc. Other key executives at Forma Therapeutics Holdings Inc include EVP & Research & Development Agustin Melian , SVP & Chief Scientific Officer David N Cook , and SVP & Chief Financial Officer Todd Shegog .

Forma Therapeutics Holdings Inc (FMTX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Forma Therapeutics Holdings Inc (FMTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Forma Therapeutics Holdings Inc (FMTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Forma Therapeutics Holdings Inc (FMTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Forma Therapeutics Holdings Inc Insider Transactions

No Available Data

Jeannette Potts Mailing Address

Above is the net worth, insider trading, and ownership report for Jeannette Potts. You might contact Jeannette Potts via mailing address: C/o Forma Therapeutics Holdings, Inc., 500 Arsenal Street, Suite 100, Watertown Ma 02472.

Discussions on Jeannette Potts

No discussions yet.